Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases

We aimed to characterize angiogenesis and proliferation and their correlation with clinical characteristics in a large brain metastasis (BM) series.

[1]  M. Weller,et al.  αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer , 2014, Clinical & Experimental Metastasis.

[2]  D. Kondziolka,et al.  It is time to reevaluate the management of patients with brain metastases. , 2014, Neurosurgery.

[3]  Y. Lotan,et al.  Ki67 is an independent predictor of oncological outcomes in patients with localized clear‐cell renal cell carcinoma , 2014, BJU international.

[4]  K. Plate,et al.  Netrin-1 Expression Is an Independent Prognostic Factor for Poor Patient Survival in Brain Metastases , 2014, PloS one.

[5]  K. Bensalah,et al.  Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma , 2014, British Journal of Cancer.

[6]  H. Heinzl,et al.  Prognostic significance of Ki67 proliferation index, HIF1 alpha index and microvascular density in patients with non-small cell lung cancer brain metastases , 2014, Strahlentherapie und Onkologie.

[7]  Frank Winkler,et al.  Invasion patterns in brain metastases of solid cancers. , 2013, Neuro-oncology.

[8]  M. Preusser,et al.  Biology in prevention and treatment of brain metastases , 2013, Expert review of anticancer therapy.

[9]  D. Rades,et al.  The first survival score for patients with brain metastases from small cell lung cancer (SCLC) , 2013, Clinical Neurology and Neurosurgery.

[10]  W. Wick,et al.  Incidence of brain metastases in patients treated with bevacizumab , 2013 .

[11]  J. Shih,et al.  Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas , 2013, Journal of Neuro-Oncology.

[12]  A. Woehrer.  Brain tumor epidemiology in Austria and the Austrian Brain Tumor Registry. , 2013, Clinical neuropathology.

[13]  W. Kaelin,et al.  The VHL/HIF axis in clear cell renal carcinoma. , 2013, Seminars in cancer biology.

[14]  T. Beißbarth,et al.  Nuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear β-catenin in cerebral metastasis of lung adenocarcinomas , 2012, Clinical & Experimental Metastasis.

[15]  D. Schadendorf,et al.  Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012. , 2012, European journal of cancer.

[16]  E. Shaw,et al.  The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery. , 2012, Journal of neurosurgery.

[17]  Umberto Ricardi,et al.  Treatment of brain metastases: review of phase III randomized controlled trials. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  S. Ha,et al.  Prognostic implications of hypoxia-inducible factor-1α in epidermal growth factor receptor-negative non-small cell lung cancer. , 2011, Lung cancer.

[19]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[20]  M. Jenkinson,et al.  Management of cerebral metastasis: evidence-based approach for surgery, stereotactic radiosurgery and radiotherapy. , 2011, European journal of cancer.

[21]  M. Wirth,et al.  Expression of the Forkhead Transcription Factor FOXP1 is Associated with Tumor Grade and Ki67 Expression in Clear Cell Renal Cell Carcinoma , 2011, Cancer investigation.

[22]  Frank Winkler,et al.  Therapy and prophylaxis of brain metastases , 2010, Expert review of anticancer therapy.

[23]  C. Szczylik,et al.  Incidence of brain metastases in renal cell carcinoma treated with sorafenib. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  B. Besse,et al.  Bevacizumab Safety in Patients with Central Nervous System Metastases , 2009, Clinical Cancer Research.

[25]  D. Kondziolka,et al.  The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline , 2009, Journal of Neuro-Oncology.

[26]  G. Song,et al.  Role of hypoxia in the hallmarks of human cancer , 2009, Journal of cellular biochemistry.

[27]  H. Heinzl,et al.  The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry , 2009, Journal of Neuro-Oncology.

[28]  N. Sibson,et al.  The Vascular Basement Membrane as “Soil” in Brain Metastasis , 2009, PloS one.

[29]  S Wolfsberger,et al.  Ki67 index in intracranial ependymoma: a promising histopathological candidate biomarker , 2008, Histopathology.

[30]  Walter Curran,et al.  A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. , 2008, International journal of radiation oncology, biology, physics.

[31]  P. Cornu,et al.  EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force , 2006, European journal of neurology.

[32]  M. Dewhirst,et al.  Expression of HIF-1α, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer , 2005 .

[33]  K. Stoeber,et al.  Mcm2, Geminin, and KI67 Define Proliferative State and are Prognostic Markers in Renal Cell Carcinoma , 2005, Clinical Cancer Research.

[34]  R. Pötter,et al.  Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  Markus Bredel,et al.  Vascular Patterns in Glioblastoma Influence Clinical Outcome and Associate with Variable Expression of Angiogenic Proteins: Evidence for Distinct Angiogenic Subtypes , 2003, Brain pathology.

[36]  S. Lange,et al.  Adjusting for multiple testing--when and how? , 2001, Journal of clinical epidemiology.

[37]  D A Hilton,et al.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. , 1999, Cancer research.

[38]  D. Kondziolka,et al.  The accuracy of predicting survival in individual patients with cancer. , 2014, Journal of neurosurgery.

[39]  George M Yousef,et al.  Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study , 2012, Laboratory Investigation.

[40]  Jochen Herms,et al.  Real-time imaging reveals the single steps of brain metastasis formation , 2010, Nature Medicine.

[41]  M. Dewhirst,et al.  Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer. , 2005, Lung cancer.

[42]  N. Weidner,et al.  Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors , 2004, Breast Cancer Research and Treatment.